GAS5 and glaucoma: To study the therapeutic effect of shGAS5 on glaucoma treatment, Meng et al. (2022) transfected shGAS5 into hTM cells and found that shGAS5 effectively decreased H2O2-induced ECM deposition by the GAS5/miR-29b-3p/STAT3 axis.